Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genetic Predictors Address The Wide Variation In Response To Weight Loss Therapy

This article was originally published in Start Up

Executive Summary

A study of gastric bypass patients has identified a gene locus that was significantly associated with less weight loss after the procedure, and two nearby genes that may be regulated in response to the bypass. The findings support the belief that the development of genetic signatures, when added to clinical predictors, can help better determine when to use specific obesity therapies in specific patients.


Related Content

Obesity Intervention: A New Era Of Discovery And Innovation
The Fight Against Fat: Start-Ups Look To Serve A Vast Market With Minimally Invasive Bariatric Devices
Bariatric Surgery Bests Medical Therapy In Treating Diabetes
Obesity 2011: Back To Basics In Bariatrics


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts